Individual-specific variation of gene expression in peripheral blood leukocytes.

DNA microarray technology is used to determine gene expression profiles of various cell types, especially abnormal cells, such as cancer. By contrast, relatively little attention has been given to expression profiling of normal tissues. Here we describe studies of gene expression in peripheral blood leukocytes (PBL) from normal individuals sampled multiple times over periods ranging from several weeks up to 6 months. We demonstrate stable patterns of gene expression that differ between individuals. Among the genes whose expression varies by individual is a group of genes responsive to interferon stimulation. Certain individuals ( approximately 10-20% of those tested) showed higher baseline levels and lower inducibility of these genes in response to in vitro interferon stimulation. These studies demonstrate the feasibility of using DNA microarrays to measure the variations in gene expression of PBL from different individuals in response to environmental and genetic factors.

[1]  Ash A. Alizadeh,et al.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Cox,et al.  Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region , 2000, Human Genetics.

[3]  M. Andreeff,et al.  Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Pitha,et al.  Multiple Regulatory Domains of IRF-5 Control Activation, Cellular Localization, and Induction of Chemokines That Mediate Recruitment of T Lymphocytes , 2002, Molecular and Cellular Biology.

[5]  R. Spielman,et al.  Natural variation in human gene expression assessed in lymphoblastoid cells , 2003, Nature Genetics.

[6]  T. Bergström,et al.  Recent origin of HLA-DRB1 alleles and implications for human evolution , 1998, Nature Genetics.

[7]  S. Pestka,et al.  Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH. , 2001, Gene.

[8]  J. Whisstock,et al.  IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes. , 1998, Genomics.

[9]  Yudong D. He,et al.  Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.

[10]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[11]  G. Cooke,et al.  Genetics of susceptibitlity to human infectious disease , 2001, Nature Reviews Genetics.

[12]  J. Chebath,et al.  Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA. , 1983, Nucleic acids research.

[13]  G. Huez,et al.  cDNA cloning and assignment to chromosome 21 ofIFI-78K gene, the human equivalent of murineMx gene , 1988, Somatic cell and molecular genetics.

[14]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[15]  S. Friend,et al.  Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Wei Chen,et al.  Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. , 2002, American journal of human genetics.

[17]  T. Kinzy,et al.  Conservation and Diversity of Eukaryotic Translation Initiation Factor eIF3* , 1997, The Journal of Biological Chemistry.

[18]  T. Niijima,et al.  Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials , 1986 .

[19]  V. Fried,et al.  Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. , 1989, Science.

[20]  P. Brown,et al.  Genomics and human disease—variations on variation , 1998, Nature Genetics.

[21]  Ash A. Alizadeh,et al.  Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Speel,et al.  Assignment of the human gene for endosarcomeric cytoskeletal M-protein (MYOM2) to 8p23.3. , 1999, Genomics.

[23]  H. Deaizpurua,et al.  Cloning and Characterization of Islet Cell Antigen-related Protein-tyrosine Phosphatase (PTP), a Novel Receptor-like PTP and Autoantigen in Insulin-dependent Diabetes* , 1996, The Journal of Biological Chemistry.

[24]  L. Newman,et al.  Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.